Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging

被引:70
作者
Fann, M
Chiu, WK
Wood, WH
Levine, BL
Becker, KG
Weng, NP
机构
[1] NIA, Immunol Lab, NIH, Baltimore, MD 21224 USA
[2] NIA, Gene Express & Genom Unit, NIH, Baltimore, MD 21224 USA
[3] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1111/j.0105-2896.2005.00262.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Accumulation of CD28(null)CD8(+) T cells is considered as one of the hallmarks of aging in the human immune system. However, the precise changes of CD28(null)CD8(+) T cells, compared to those of the precursor CD28(+)CD8(+) memory T cells, have not been determined. In this study, we present an analysis of the global gene expression profiles of CD28(+) and CD28(null) memory phenotype CD8(+) T cells. These two CD8(+) T subsets exhibited an overall similar gene expression profile with only a few dozen genes that were differentially expressed. A wide range of functions, including co-stimulation, effector activity, signaling, and transcription, were possessed by these differentially expressed genes, reflecting significant functional changes of CD28(null) memory phenotype CD8(+) T cells from their CD28(+) counterparts. In addition, CD28(null) memory CD8(+) T cells expressed several natural killer cell receptors and high levels of granzymes, perforin, and FasL, indicating an increasing capacity for cytotoxicity during memory CD8(+) T-cell aging. Interestingly, in vitro culture of these two subsets with interleukin-15 showed that similar gene expression changes occurred in both subsets. Our analysis provides the gene expression portraits of CD28(null) memory phenotype CD8(+) T cells and alteration from their CD28(+) counterparts and suggests potential mechanisms of T-cell aging.
引用
收藏
页码:190 / 206
页数:17
相关论文
共 131 条
[101]  
2-9
[102]   In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes [J].
Speiser, DE ;
Pittet, MJ ;
Valmori, D ;
Dunbar, R ;
Rimoldi, D ;
Liénard, D ;
MacDonald, HR ;
Cerottini, JC ;
Cerundolo, V ;
Romero, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (06) :775-782
[103]   The activatory receptor 2B4 is expressed in vivo by human CD8+ effector αβ T cells [J].
Speiser, DE ;
Colonna, M ;
Ayyoub, M ;
Cella, M ;
Pittet, MJ ;
Batard, P ;
Valmori, D ;
Guillaume, P ;
Liénard, D ;
Cerottini, JC ;
Romero, P .
JOURNAL OF IMMUNOLOGY, 2001, 167 (11) :6165-6170
[104]   LNB-TM7, a group of seven-transmembrane proteins related to family-B G-protein-coupled receptors [J].
Stacey, M ;
Lin, HH ;
Gordon, S ;
McKnight, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (06) :284-289
[105]   Antigen-driven effector CD8 T cell function regulated by T-bet [J].
Sullivan, BM ;
Juedes, A ;
Szabo, SJ ;
von Herrath, M ;
Glimcher, LH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15818-15823
[106]   A novel transcription factor, T-bet, directs Th1 lineage commitment [J].
Szabo, SJ ;
Kim, ST ;
Costa, GL ;
Zhang, XK ;
Fathman, CG ;
Glimcher, LH .
CELL, 2000, 100 (06) :655-669
[107]   DEVELOPMENTAL COMMITMENT TO THE TH2 LINEAGE BY EXTINCTION OF IL-12 SIGNALING [J].
SZABO, SJ ;
JACOBSON, NG ;
DIGHE, AS ;
GUBLER, U ;
MURPHY, KM .
IMMUNITY, 1995, 2 (06) :665-675
[108]   T-CELL ADHESION INDUCED BY PROTEOGLYCAN-IMMOBILIZED CYTOKINE MIP-1-BETA [J].
TANAKA, Y ;
ADAMS, DH ;
HUBSCHER, S ;
HIRANO, H ;
SIEBENLIST, U ;
SHAW, S .
NATURE, 1993, 361 (6407) :79-82
[109]   NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals:: defective expression of CD56 [J].
Tarazona, R ;
DelaRosa, O ;
Casado, JG ;
Torre-Cisneros, J ;
Villanueva, JL ;
Galiani, MD ;
Peña, J ;
Solana, R .
AIDS, 2002, 16 (02) :197-200
[110]   Granzyme B: pro-apoptotic, antiviral and antitumor functions [J].
Trapani, JA ;
Sutton, VR .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (05) :533-543